Cyril Honsik

Lymphokine-activated killer cells targeted by monoclonal antibodies to the disialogangliosides GD2 and GD3 specifically lyse human tumor cells of neuroectodermal origin.

Cyril Honsik, Gundram Jung, R. Reisfeld · Proceedings of the National Academy of Sciences · 1986 · 109 citations

Immunology, Immunologic Mechanism, Immunotherapy +16

Disialoganglioside GD3 on human melanoma serves as a relevant target antigen for monoclonal antibody-mediated tumor cytolysis.

David A. Cheresh, Cyril Honsik, L K Staffileno et al. · Proceedings of the National Academy of Sciences · 1985 · 96 citations · Full text

Disialoganglioside Gd3, Tumor Biology, Cancer Immunosurveillance +13

Activation of human peripheral blood mononuclear cells by anti-T3: killing of tumor target cells coated with anti-target-anti-T3 conjugates.

Gundram Jung, Cyril Honsik, R. Reisfeld et al. · Proceedings of the National Academy of Sciences · 1986 · 61 citations

Immunology, Cytotoxic T-cell Clones, Cell Death +18

Marrow-thymus interactions during radiation leukemogenesis in C57BL/Ka mice.

Jacques Boniver, A. Declève, Miriam Lieberman et al. · PubMed · 1981 · 61 citations

Days Postirradiation, Cell Therapy, Radiation Medicine +15

Macrophage and lymphocyte-depleted thymus reticuloepithelial cell cultures: establishment and functional influence on T-lymphocyte maturation, C-type virus expression and lymphomatous transformation in vitro.

Jacques Boniver, A. Declève, Dailey Mo et al. · PubMed · 1981 · 29 citations